Home 
 
Joe,Young Ae
Á¶¿µ¾Ö(Àç»ýÀÇÇÐ)
: ºÐÀÚ-¼¼Æ÷»ý¹°ÇÐ
: Á¾¾ç»ýÈ­ÇÐ, Áٱ⼼Æ÷ÇÐ
: 3147-8406
: 3147-8606
: youngjoe@catholic.ac.kr
:
¿¬µµ Çб³ Àü°ø ÇÐÀ§
1988³â-1992³â ¼­¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇаú »ýÈ­ÇÐ ¹Ú»ç
1986³â-1988³â ¼­¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇаú »ýÈ­ÇÐ ¼®»ç
1982³â-1986³â ¼­¿ï´ëÇб³ ¾àÇдëÇÐ ¾àÇаú ¾àÇÐ Çлç
¿¬µµ ±â°ü Á÷À§
2010³â-ÇöÀç °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇ»ý¸í°úÇб³½Ç & ¾Ï¿¬±¸¼Ò ±³¼ö
2005³â-2010³â °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¾Ï¿¬±¸¼Ò ºÎ±³¼ö
2000³â-2005³â °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¾Ï¿¬±¸¼Ò Á¶±³¼ö
1997³â-2000³â °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¾Ï¿¬±¸¼Ò ÀüÀÓ°­»ç
1992³â-1997³â ¹Ì±¹ National Institutes of Health Post-Doc.
±â°£ ÇÐȸ¸í/±â°ü Á÷À§
2014³â Á¦24ȸ °úÇбâ¼ú ¿ì¼ö³í¹®»ó Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ
2009³â-ÇöÀç Biomolecules & Therapeutics(www.biomolther.org) Editor-in-Chief
2003³â-ÇöÀç American Association for Cancer Research Á¤È¸¿ø
2010-ÇöÀç International Society for Stem Cell Research Á¤È¸¿ø
2008³â ¿ì¼ö¿¬±¸ÀÚ»ó ´ëÇѾÏÇÐȸ
2008³â 13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine Award for an outstanding achievement
2010³â-ÇöÀç Çѱ¹ÀÀ¿ë¾à¹°ÇÐȸ ÀÌ»ç
2015³â-ÇöÀç Çѱ¹Ç÷°ü»ý¹°ÇÐȸ ÀÌ»ç
2004³â ´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ÇмúÀ§¿ø
2003³â Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ ÃâÆÇÀ§¿ø
▫ »ý¹°Á¤º¸ÇÐ (À¯ÀüÀÚ¿Í ´Ü¹éÁú ºÐ¼®¿¡ °üÇÑ ½Ç¿ëÁöħ¼­) °ø¿ª. ±¸È¿Á¤, ±èÁ¤Èñ, ±èÁö¿µ, ±èÈ«Èñ, ¹®¾Ö¸®, ¹ÚÇö¼º, ¾È»óÇö, ¿ÀÀ¯°æ, À̳ª°æ, À̹̿Á, À̼÷°æ, À̼÷Çâ, ÀÌ¿µÁÖ, ÀÌ¿ë±Ô, ÀÌÀº¼÷, Á¤¼±ÁÖ, Á¤À̼÷, Á¶¿µ¾Ö. 2003. µµ¼­ÃâÆÇ ¿ùµå»çÀ̾ð½º
±¸ ºÐ Ãâ¿ø/µî·Ï ÁöÀûÀç»ê±Ç(ƯÇã)¸í µî·Ï(Ãâ¿ø)¹øÈ£ µî·Ï(Ãâ¿ø)ÀÏ °øµ¿¹ß¸íÀÚ
±¹³» µî·Ï Ç÷°ü½Å»ý°ú ¾ÏÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÏ´Â Å©¸µ±Û µµ¸ÞÀÎ 1-2 ´Ü¹éÁú Á¶¼º¹° ¹× ÀÌÀÇ ¿ëµµ 0538465 2005.12 Á¶¿µ¾Ö,À̼ö¿µ
±¹Á¦ Ãâ¿ø Ç÷°ü½Å»ý ¾ïÁ¦ È°¼ºÀ» °®´Â ÆéŸÀÌµå ¹× ÀÌÀÇ ¿ëµµ PCT Ãâ¿ø: OP11-1043 2011.09 Á¶¿µ¾Ö,±èÇö°æ
¹Ì±¹ µî·Ï Æä·Ï½Ã´Ù½Å ¾ïÁ¦Á¦¸¦ À¯È¿¼ººÐÀ¸·Î Æ÷ÇÔÇÏ´Â Ç÷°ü½Å»ý¾ïÁ¦¿ë Á¶¼º¹° PCT Ãâ¿ø OP11-1055 2015.03 Á¶¿µ¾Ö,±èÇö°æ
±¹³» µî·Ï ³»ÇÇÀü±¸¼¼Æ÷ÀÇ Ã¼¿Ü ÁõÆø¹æ¹ý 10-1132858 2012.03 Á¶¿µ¾Ö, ¿ÀÀºÁÖ, ¾ÈÇö¿µ, ½ÅÁ¾Ã¶
±¹³» µî·Ï ROCK ÀúÇØÁ¦ ½ºÅ©¸®´× ¹æ¹ý 10-1252958 2013. 04 Á¶¿µ¾Ö, ÀÌÇö¼±
Á¦¸ñ

The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Lee SW, Kim HK, Lee NH, Yi HY, Kim HS, Hong SH, Hong YK, Joe YA. Cancer Lett. 360: 195-204 (2015)  


Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Choi M, Lee HS, Naidansaren P, Kim HK, O E, Cha JH, Ahn HY, Yang PI, Shin JC, Joe YA. Int J Biochem Cell Biol. 45, 560-570 (2013) 


Efficient non-adhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization. Eunju O, Byung Hun Lee, Hyun-Young Ahn, Jong-Chul Shin, Hyun-Kyung Kim, Myungshin Kim, In-Yang Park, Yong-Gyu Park, and Young Ae Joe. FASEB Journal. 2011, 25 (1) : 159-169


Antimigratory effect of TK1-2 is mediated in part by interfering with integrin a2b1. Hyun-Kyung Kim, Dae-Shik Oh, Sang-Bae Lee, Jung-Min Ha, Young Ae Joe. Molecular Cancer Therapeutics. 2008, 7 : 2133-2141



Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Ho-Kyun Oh, Jung-Min Ha, Eunju O, Byung Hun Lee, Byoung-Shik Shim, Yong-Kil Hong, Suk Keun Lee and Young Ae Joe. Cancer Research. 2007, 67(10) : 4851-4859